Glory Adebayo | Parasitology | Best Researcher Award

Published on by Zoology Honour

Ms. Glory Adebayo | Parasitology | Best Researcher Award

Research Associate at Nigerian Institute of Medical Research, Nigeria

Glory Pipeloluwa Adebayo is a dedicated biomedical researcher specializing in molecular biology, bioinformatics, and malaria drug discovery. She is currently a Research Fellow at the Nigerian Institute of Medical Research (NIMR), where she leads studies on Plasmodium falciparum resistance and antimalarial therapeutics. With extensive expertise in molecular diagnostics, immunology, and in vitro drug assays, she has contributed significantly to infectious disease research. Her work has resulted in multiple high-impact publications, and she has trained several young scientists in laboratory techniques. She has also participated in international research collaborations, including training at the Swiss Tropical and Public Health Institute. Her contributions to malaria research extend to both computational and laboratory-based studies, making her a prominent figure in the field. She aspires to develop innovative treatment strategies for infectious diseases through interdisciplinary research and technological advancements.

Professional Profiles📖

Scopus

Education 🎓

Glory is a dedicated researcher with a strong academic background in biological sciences. She earned her B.Sc. (Hons) in Biochemistry from the University of Lagos, Nigeria, with a commendable GPA of 4.08/5.00. She then pursued an M.Sc. in Cell Biology and Genetics at the same institution, graduating with a stellar GPA of 4.29/5.00. Currently, she is completing her Ph.D. in Biology at Covenant University, where her research is centered on antimalarial drug discovery. Her work integrates both computational and laboratory-based approaches to experimental drug development, positioning her at the forefront of innovative biomedical research. Beyond her academic achievements, Glory has gained valuable hands-on experience, including her service at the Abia State Hospital and Diagnostic Centre during her National Youth Service Corps (NYSC) year. She has honed her expertise in molecular techniques, bioinformatics, and pharmaceutical research, contributing to international collaborations, conference presentations, and high-impact scientific publications. With a passion for advancing global health through cutting-edge research, she remains committed to making significant contributions to drug discovery and disease treatment.

Awards and Honors 🏆

Glory’s dedication to research, international collaboration, and academic excellence in biomedical sciences is evident through her numerous prestigious awards and fellowships. In 2024, she was awarded a Research Fellowship at the Nigerian Institute of Medical Research (NIMR), recognizing her contributions to malaria therapeutic efficacy studies and molecular diagnostics. Her commitment to global health research was further acknowledged in 2022 when she received the Swiss TPH Training Fellowship at the Swiss Tropical and Public Health Institute, where she honed her expertise in Plasmodium falciparum drug assays and mammalian cell culture techniques. Earlier in her career, Glory was recognized as the Best Graduate Research Intern at NIMR in 2019 for her outstanding work in molecular diagnosis and Plasmodium resistance studies. Her academic excellence was also celebrated at the University of Lagos, where she received the Academic Excellence Award in 2016. These accolades highlight her passion for scientific discovery, her ability to excel in competitive research environments, and her ongoing contributions to biomedical science and infectious disease research.

Work Experience💼

Glory’s research experience spans academia, public health institutions, and international research centers, showcasing her interdisciplinary expertise in infectious disease research. Currently serving as a Research Fellow at the Nigerian Institute of Medical Research (NIMR), she leads malaria therapeutic efficacy studies, molecular diagnostics, and ELISA-based immunological assessments. Prior to this, she worked as a Research Assistant at Covenant University’s Bioinformatics Research Unit, where she conducted Plasmodium and mammalian cell cultures, toxicity assays, and molecular docking analyses. Her commitment to advancing malaria research led her to the Swiss Tropical & Public Health Institute in 2022, where she received specialized training in Plasmodium falciparum drug assays and mammalian cell culture techniques. She also gained hands-on experience as a Graduate Research Intern at NIMR in 2019, assisting in the molecular diagnosis of human blood samples and Plasmodium resistance studies. Beyond her research-focused roles, she worked as a Pharmacy Assistant at Crest Health Pharmacy in 2017, managing drug inventory and supporting pharmaceutical services. With a solid foundation in both laboratory and clinical research, Glory continues to contribute meaningfully to global infectious disease control efforts.

Skills💡

Glory possesses a diverse skill set that spans molecular biology, cell culture, immunology, bioinformatics, animal studies, lab management, and scientific writing. Her expertise in molecular biology includes DNA/RNA extraction, PCR, gel electrophoresis, and molecular docking, enabling her to conduct precise genetic and protein-based analyses. She is also proficient in cell culture techniques, working with Plasmodium and mammalian cells to perform in vitro drug assays that contribute to antimalarial drug discovery. Her immunology experience includes ELISA-based assays and serological testing, crucial for evaluating immune responses in infectious disease research. In bioinformatics, she specializes in data mining, next-generation sequencing (NGS) analysis, and omics data integration, allowing her to analyze large-scale biological data sets. Additionally, she has hands-on experience with murine malaria models, conducting toxicity assays and drug efficacy testing to validate therapeutic interventions. Beyond her technical skills, Glory is adept at lab management, ensuring compliance with safety protocols, maintaining accurate data records, and developing standard operating procedures (SOPs). She is also an accomplished scientific writer, with experience in manuscript preparation, grant writing, and proposal development, reinforcing her ability to contribute to high-impact research publications and secure funding for innovative projects.

Research Focus 🔬

Glory Adebayo is a dedicated researcher specializing in malaria research, with a focus on molecular drug discovery, Plasmodium resistance characterization, and bioinformatics applications. Her work integrates computational drug design, in vitro and in vivo antimalarial assays, and genetic analysis of resistant strains to advance the fight against malaria. She is particularly interested in post-GWAS (genome-wide association study) analysis, where she develops omics-based tools to study malaria epidemiology and identify potential therapeutic targets.

Beyond malaria research, Glory has contributed to studies on viral infections and antimicrobial resistance, expanding her impact within infectious disease research. Her interdisciplinary approach seamlessly combines wet-lab techniques with computational biology, enabling her to bridge experimental and computational methodologies. Through her research, she aims to develop effective therapeutics and innovative strategies to combat infectious diseases, ultimately improving global public health outcomes.

Publications Top Notes📚

 

Title: The Importance of Murine Models in Determining In Vivo Pharmacokinetics, Safety, and Efficacy in Antimalarial Drug Discovery.​

Journal: Pharmaceuticals.​Preprints+1MDPI+1

Publication Date: March 2025.​

DOI: 10.3390/ph18030424.

Songmin Ying | Immunology | Best Researcher Award

Published on by Zoology Honour

Prof. Dr. Songmin Ying | Immunology | Best Researcher Award

MD, PhD at Zhejiang University, China

Songmin Ying is a Qiushi Distinguished Professor and Doctoral Supervisor at Zhejiang University School of Medicine. He serves as the Executive Dean and Director of the Zhejiang-Denmark Joint Laboratory for Regenerative and Aging Medicine. His research focuses on chronic airway diseases, aging medicine, and pharmacology. Dr. Ying has held various prestigious academic and research positions, including at the University of Oxford and the Technical University of Munich. With an extensive publication record in high-impact journals, he has significantly contributed to immunology, oncology, and respiratory medicine. His pioneering research has garnered numerous accolades, cementing his reputation as a leader in biomedical sciences.

Professional Profiles📖

Google Scholar

Education 🎓

Dr. Ying’s academic journey began at Shantou University School of Medicine, where he earned his Bachelor’s degree in Clinical Medicine (2003-2007). He then pursued a Master’s in Molecular Genetic Medicine at the University of Sheffield (2007-2010), followed by a Doctorate in Biochemistry at the Technical University of Munich (2010-2013). His postdoctoral training took place at the University of Oxford in the Department of Oncology and the Weatherall Institute of Molecular Medicine. This diverse and prestigious academic background has equipped him with expertise in molecular medicine, respiratory diseases, and translational pharmacology.

Work Experience💼

Dr. Ying’s career is marked by leadership roles in medical research and academia. He has been a Research Fellow and Professor at the Institute of Respiratory Diseases, Zhejiang University, since 2013. In 2023, he was appointed Executive Dean of Zhejiang University School of Medicine, where he oversees groundbreaking biomedical research. His role as Director of the Zhejiang-Denmark Joint Laboratory for Regenerative and Aging Medicine reflects his global research collaborations. His extensive international experience includes significant contributions at the University of Oxford and other renowned institutions.

Awards and Honors 🏆

Dr. Ying has received numerous awards for his contributions to medical research, particularly in immunology and respiratory diseases. He has been recognized with the Qiushi Distinguished Professorship, Zhejiang University’s highest honor. His research has also earned prestigious grants and fellowships, reflecting his impact on aging medicine and airway disease research. He has been invited as a keynote speaker at leading medical conferences worldwide, further solidifying his influence in the scientific community.

Skills💡

Dr. Ying possesses expertise in molecular biology, immunology, pharmacology, and respiratory medicine. His skills include high-throughput sequencing, CRISPR gene editing, and advanced imaging techniques. He is also proficient in bioinformatics analysis and translational medicine strategies. As an academic leader, he has extensive experience in mentoring PhD students and leading multidisciplinary research teams. His collaboration with international institutions enhances his ability to drive innovation in medical sciences.

Research Focus 🔬

Dr. Ying’s research centers on chronic airway diseases, aging medicine, and pharmacology. His work explores the molecular mechanisms of immune responses in respiratory disorders, with an emphasis on eosinophilic inflammation and metabolic adaptation in allergic diseases. He investigates aging-related pathologies and regenerative medicine, aiming to develop targeted therapies for age-associated respiratory diseases. His interdisciplinary approach integrates genomics, bioinformatics, and experimental medicine, positioning his work at the forefront of translational research.

Conclusion✅

Professor Songmin Ying is highly deserving of the Best Researcher Award due to his exceptional research output, leadership, and impact on biomedical sciences. His contributions to chronic diseases, immunology, and aging medicine are globally recognized, making him a strong contender. Further clinical applications and public engagement could enhance his influence even more.

Publications Top Notes📚

Replication stress induces sister-chromatid bridging at fragile site loci in mitosis

Citations: 674

Year: 2009

Replication stress activates DNA repair synthesis in mitosis

Citations: 571

Year: 2015

Mre11-dependent degradation of stalled DNA replication forks is prevented by BRCA2 and PARP1

Citations: 394

Year: 2012

MUS81 promotes common fragile site expression

Citations: 281

Year: 2013

Chlamydia Inhibit Host Cell Apoptosis by Degradation of Proapoptotic BH3-only Proteins

Citations: 253

Year: 2004

Mechanisms for stalled replication fork stabilization: new targets for synthetic lethality strategies in cancer treatments

Citations: 209

Year: 2018

Activation of MTOR in pulmonary epithelium promotes LPS-induced acute lung injury

Citations: 201

Year: 2016

Autophagy is essential for ultrafine particle-induced inflammation and mucus hyperproduction in airway epithelium

Citations: 178

Year: 2016

Genetic alterations in esophageal tissues from squamous dysplasia to carcinoma

Citations: 170

Year: 2017

Recruitment of BAD by the Chlamydia trachomatis vacuole correlates with host-cell survival

Citations: 158

Year: 2006

Long-term efficacy and safety of omalizumab in patients with persistent uncontrolled allergic asthma: a systematic review and meta-analysis

Citations: 140

Year: 2015

Pathological roles of neutrophil‐mediated inflammation in asthma and its potential for therapy as a target

Citations: 123

Year: 2017

Inactivation of MTOR promotes autophagy-mediated epithelial injury in particulate matter-induced airway inflammation

Citations: 114

Year: 2020

LncRNA H19 promotes the proliferation of pulmonary artery smooth muscle cells through AT1R via sponging let-7b in monocrotaline-induced pulmonary arterial hypertension

Citations: 106

Year: 2018

MTOR suppresses cigarette smoke–induced epithelial cell death and airway inflammation in chronic obstructive pulmonary disease

Citations: 102

Year: 2018

DNA-PKcs and PARP1 bind to unresected stalled DNA replication forks where they recruit XRCC1 to mediate repair

Citations: 96

Year: 2016

Broad Degradation of Proapoptotic Proteins with the Conserved Bcl-2 Homology Domain 3 during Infection with Chlamydia trachomatis

Citations: 94

Year: 2005

ARIH1 signaling promotes anti-tumor immunity by targeting PD-L1 for proteasomal degradation

Citations: 88

Year: 2021

Effectiveness and safety of PD-1/PD-L1 inhibitors in the treatment of solid tumors: a systematic review and meta-analysis

Citations: 85

Year: 2017

Autophagy plays an essential role in cigarette smoke-induced expression of MUC5AC in airway epithelium

Citations: 82

Year: 2016